Michael Wirth
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Glycosylation and Glycoproteins Research 18
-
- Advanced Drug Delivery Systems 15
- Advancements in Transdermal Drug Delivery 8
- Co-authors
- Franz Gabor (77 shared papers)Claudia Valenta (10 shared papers)Helmut Viernstein (9 shared papers)Stefan Toegel (9 shared papers)Lukas Neutsch (10 shared papers)Fritz Pittner (6 shared papers)Winfried Neuhaus (8 shared papers)Christian R. Noe (7 shared papers)
- Journals
- International Journal of Pharmaceutics (13 papers)European Journal of Pharmaceutics and Biopharmaceutics (10 papers)Journal of Controlled Release (10 papers)Pharmaceutical Research (5 papers)Journal of Drug Delivery Science and Technology (3 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Michael Wirth
118 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 132
- Pharmaceutical Science 720
- Biomaterials 550
- Neurology 149
- Molecular Medicine 91
- Geriatrics and Gerontology 55
Countries citing papers authored by Michael Wirth
This map shows the geographic impact of Michael Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wirth more than expected).
Fields of papers citing papers by Michael Wirth
This network shows the impact of papers produced by Michael Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wirth. The network helps show where Michael Wirth may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Wirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 228 | |
| 2 | 2002 | 119 | |
| 3 | 2004 | 92 | |
| 4 | 1999 | 85 | |
| 5 | 2010 | 84 | |
| 6 | 2006 | 82 | |
| 7 | 1998 | 75 | |
| 8 | 1988 | 73 | |
| 9 | 1998 | 72 | |
| 10 | 2003 | 71 | |
| 11 | 2002 | 68 | |
| 12 | 1995 | 67 | |
| 13 | 2004 | 58 | |
| 14 | 2007 | 58 | |
| 15 | 2013 | 57 | |
| 16 | 2004 | 54 | |
| 17 | 2000 | 53 | |
| 18 | 2008 | 50 | |
| 19 | 1997 | 49 | |
| 20 | 2011 | 48 |
About Michael Wirth
Michael Wirth is a scholar working on Molecular Biology, Pharmaceutical Science, Biomedical Engineering, Surgery and Biomaterials, having authored 119 papers that have together received 3.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (18 papers), Advanced Drug Delivery Systems (15 papers), Bladder and Urothelial Cancer Treatments (10 papers), Nanoparticle-Based Drug Delivery (9 papers), Urinary Bladder and Prostate Research (8 papers), Microfluidic and Bio-sensing Technologies (8 papers), Advancements in Transdermal Drug Delivery (8 papers) and Urinary Tract Infections Management (7 papers). The work is most often cited by research in Pharmaceutical Science (720 citations), Biomaterials (550 citations), Neurology (149 citations), Molecular Medicine (91 citations) and Geriatrics and Gerontology (55 citations). Michael Wirth has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Franz Gabor, Claudia Valenta, Helmut Viernstein, Stefan Toegel, Lukas Neutsch, Fritz Pittner, Winfried Neuhaus, Christian R. Noe, P Arbós and Juan M. Irache. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Controlled Release, Pharmaceutical Research and Journal of Drug Delivery Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.